94 Banyal and Sharmaneither Glu-Cys nor GSH can traverse the parasitemembrane. This allows the parasite to efficientlyengage in de novo glutathione synthesis without losingthe intermediate or the final products and to makeabundant use of the reducing capacity of GSH (Roth,1987).Glutathione and hemoglobin digestion: Hemoglobinis degraded by Plasmodium during intraerythrocyticstages and in the process haem is released (Banyal andFitch, 1982). Haem is a toxic molecule to malariaparasite. <strong>The</strong> parasite detoxifies haem bypolymerization and degradation. <strong>The</strong> parasiteconverts almost 30% of haem into haemozoin ormalarial pigment, while rest of the haem is degradedby reduced glutathione. Glutathione degrades haemwhether it is free in solution or it is boundnonspecifically to protein by conjugation. Glutathionemetabolism is there<strong>for</strong>e, essential <strong>for</strong> the survival ofmalaria parasite (Ginsburg et al., 1998; Padmanabanet al., <strong>2007</strong>).Fig. 3. Trypanothione.synthesis of GSH and its subsequent conjugation tospermidine. GSH is synthesized by two enzymes,which are common with malarial parasite, while theconjugation of GSH to spermidine is catalyzed by twotrypanothione specific enzymes (Opperdoes andCoombs, <strong>2007</strong>). Since this thiol is absent from humansand is essential <strong>for</strong> the survival of these parasites, theenzymes that make and use this molecule are targets<strong>for</strong> the development of new drugs to treat the diseasescaused by these parasitic protozoa (Schmidt andKrauth-Siegel, 2002). Trypanothione-dependentenzymes include reductases, peroxidases, glyoxalasesand transferases.ENZYMES OF GLUTATHIONE METABOLISMIN PARASITIC PROTOZOA: Although themetabolic pathway has not been investigated in anydetail, -glutamylcysteine synthetase (Lueder andPhillips, 1996; Luersen et al., 2000), glutathionesynthetase (Meierjohann et al., 2002a), glutathione-S-transferases (Harwaldt et al., 2002) and glutathionereductase (Farber et al., 1996) have been extensivelystudied in various protozoa, which suggests that aglutathione metabolic pathway similar to mammals ispresent in these parasites. Such studies may perhapshelp in structure based approaches to the developmentof antimalarials (Brady and Cameron, 2004).1. γ-glutamylcysteine synthetase(γ-GCS;glutamate-cysteine ligase EC 6.3.2.2): γ-GCScatalyses the first and rate limiting step in glutathionebiosynthesis. <strong>The</strong> gene <strong>for</strong> γ-GCS has been isolatedand characterized in various parasitic protozoa(Lueder and Phillips, 1996; Luersen et al., 2000). γ-GCS activity was 3.76-fold higher in P. berghei ascompared to normal mice erythrocytes and 1.4-foldhigher compared to P. berghei infected erythrocytes(our unpublished data).Glutathione and drug resistance: Most of theantimalarial drugs interact with haem and <strong>for</strong>m acomplex, which is highly toxic to biologicalmembranes (Fitch et al., 1982). Glutathione competeswith antimalarial drugs <strong>for</strong> degrading haem toxin, andis thus associated with drug resistance. Growthinhibition of P. falciparum chloroquine-sensitivestrain (3D7) by buthionine (S,R)- sulfoximine (BSO, aspecific inhibitor of -GCS) and by methylene blue, aninhibitor of GR, was significantly more pronouncedthan inhibition of P. falciparum CQ-resistant strain(Dd 2) growth by antimalarial drugs (Meierjohann etal., 2002a). Also in vivo studies on P. berghei and P.vinckei-infected mice showed that drugs such asacetaminophen, indomethacin and disulphiram,which produce an indirect decrease in GSH, potentiatethe antimalarial action of the sub-curative doses of CQand amodiaquine (Deharo et al., 2003; Zuluaga et al.,<strong>2007</strong>).Glutathione metabolism and trypanosomatids: Inplace of glutathione, trypanosomatids includingcausative agents of African sleeping sickness(Trypanosoma brucei gambiense), Chagas disease (T.cruzi) and different leishmanial parasites utilizetrypanothione, a conjugate of GSH and spermidine, tomaintain the redox balance of the cells (Fairlamb et al.,1985). It is an unusual <strong>for</strong>m of glutathione containingtwo molecules of glutathione joined by a spermidine(polyamine) linker (Fig. 3). Trypanothione intrypanosomatids is synthesized in four steps via theCOOHONHNHH 2 NNHOOSHNHOSHOH 2 NNHNHNHCOOHO
Glutathione metabolism in protozoa95<strong>The</strong> T. brucei γ-GCS gene contains 2037 base pairs studies of the Plasmodium gene are underway towhich code <strong>for</strong> 679 amino acids of a 77.4 kDa protein. address this point. BSO was also found to be anFurther, T.brucei γ-GCS is a single copy gene and the effective antileishmanial agent against Leishmaniaamino acid sequence shares 36–45% sequence donovani promastigotes in vitro and also inhibitedidentity with other eukaryotic enzymes (Huang et al., intracellular amastigote multiplication (Weldrick et1995). T. brucei γ-GCS showed apparent Km values al., 1999; Kapoor et al., 2000). At the concentrations<strong>for</strong> the three natural substrates L-Glu, L-Cys and ATP used <strong>for</strong> promastigotes, the inhibitor has minimalas 0.24 mM, 0.69 mM and 0.07 mM, respectively. effect on macrophages. <strong>The</strong> potent anti-leishmanialeffect of this inhibitor at in vitro level and its selectiveUnlike the mammalian enzyme L-γ-aminobutyrate is ainhibitory activity towards the parasite makes it apoor substitute <strong>for</strong> L-Cys in T.brucei catalysedprobable chemotherapeutic agent against kala-azarreaction. T. brucei γ-GCS feedback is inhibited byalso.glutathione (apparent K I=1.1mM) and it is inactivatedby cystamine and buthionine sulphoximine (BSO; 2. Glutathione synthetase (GS; γ-L-glutamate-L-Arrick et al., 1981). <strong>The</strong> kinetic properties of cysteine: glycine ligase EC 6.3.2.3): Glutathionerecombinant T. brucei γ-GCS suggest that substrate synthetase catalyzes the final step in glutathionebinding pocket and the mechanism of enzyme biosynthesis. Among parasitic protozoa, this enzymeregulation differ from the mammalian enzyme, which has been extensively studied in malaria parasiteprovide evidence that T. brucei γ-GCS could be a (Meierjohann et al., 2002a). GS activity observed in P.selective chemotherapeutic target <strong>for</strong> the treatment of berghei was 5.52-fold higher than normal totaltrypanosomiasis (Gillespie et al., <strong>2007</strong>). Genes of erythrocytes and 1.95-fold more than P. bergheidifferent P. falciparum strains contained 4206 bp or infected total erythrocytes (our unpublished4038 bp and a variable number of repeats at N- observation). PfGS gene encodes a polypeptide of 655terminal (Luersen et al., 1999). P. falciparum γ-GCS amino acids. <strong>The</strong> sequence is much larger than GS in(Pfggcs) gene encodes polypeptide of 1119 and 1063 other organisms (Gali and Board, 1997), attributableamino acids. <strong>The</strong> deduced amino acid sequences show to several insertions in the Plasmodium sequence.four regions of homology (31.3-43.9%) to human and <strong>The</strong>se insertions have nothing to do with stability andT. brucei (Gillespie et al., <strong>2007</strong>). <strong>The</strong>se regions are cofactor binding of the enzyme. Abundance ofinterrupted by three large insertions between 94 and asparagine, glutamine and glutamic acid helps in239 amino acids, which are responsible <strong>for</strong> the circumvention of the host cell immune systemdifferent sizes of the sequences. <strong>The</strong> predicted (Schofield, 1991). Highly conserved region of themolecular mass of the proteins from different P. enzyme in P. falciparum Cys-517 to Cys-525falciparum strains ranges from 124.4 kDa to 133.2 corresponds to Gly-164 to Gly-167 sequence in thekDa which is almost twice that of the catalytic subunit eukaryotic (Gali and Board, 1997) and E. coli GSof the human host enzyme. <strong>The</strong> γ-GCS shows a stage (Tanaka et al., 1992).specific transcription pattern. <strong>The</strong> transcription beginsPfGS protein is active as a homodimer with a subunitin the young trophozoite stage (12–18 h), peaks insize of 77kDa. <strong>The</strong> Km values <strong>for</strong> γ-glutamyl-αmaturetrophozoites and decreases in the schizontaminobutyrate, ATP and glycine are 0.107mM,stage (36–42 h; Perez-Rosado et al., 2002). P. berghei0.059mM and 5.04mM, respectively, and arecontains cytosolic γ-GCS with 0.711±0.001 units/mgcomparable with that of mammalian enzymeprotein. <strong>The</strong> enzyme was observed as a heterodimer(Njalsson et al., 2000) but negative cooperative effectwith subunits of apparent molecular weights 66 kDaof γ-glutamyl-γ-aminobutyrate was not found. Alsoand 57 kDa, and has Km of 0.75 mM <strong>for</strong> L-glutamate.parasite GS has quite distinct amino acid residues at γ-As BSO acts specifically on γ-GCS, it can be used as aglutamylcysteine binding site (Meierjohann et al.,research tool that efficiently depletes GSH without2002b). Sharma and Banyal (<strong>2007</strong>) reported P. bergheiaffecting other metabolic pathways or proteins.contained 0.443±0.001 units of GS/mg protein.However, the inhibitor not only acts on the parasitePurified 70 kDa GS showed Km value of 1.33 mM,enzyme but also inhibits the host cell γ-GCS activity1.17mM and 1.81mM <strong>for</strong> γ-glutamylcysteine, ATP(Meierjohann et al., 2002b). <strong>The</strong>re<strong>for</strong>e, it remains toand glycine, respectively, with noncompetitivebe shown that it is indeed the inhibition of Plasmodiuminhibition by glutathione. P. berghei GS was foundγ-GCS that impairs parasite survival and knock outantigenically active and induces humoral response in